Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Doxorubicin and Paclitaxel Versus Doxorubicin and Cyclophosphamide as First-Line Chemotherapy in Metastatic Breast Cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial
PaperCitations, authors & open-access status
Doxorubicin and Paclitaxel Versus Doxorubicin and Cyclophosphamide as First-Line Chemotherapy in Metastatic Breast Cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 220 citations, 2002 year and closed oa status.
220
Citations
2002
Year
closed
OA Status